1. Home
  2. TECX vs ITG Comparison

TECX vs ITG Comparison

Compare TECX & ITG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$32.34

Market Cap

618.9M

Sector

N/A

ML Signal

HOLD

ITG

ITG Inc. Class A Common Stock

N/A

Current Price

$13.40

Market Cap

667.6M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
ITG
Founded
2019
N/A
Country
United States
United States
Employees
60
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
667.6M
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
TECX
ITG
Price
$32.34
$13.40
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$75.20
N/A
AVG Volume (30 Days)
150.1K
394.2K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$10.37
52 Week High
$39.53
$16.00

Technical Indicators

Market Signals
Indicator
TECX
ITG
Relative Strength Index (RSI) 57.13 50.56
Support Level $27.30 $12.80
Resistance Level $35.99 $14.09
Average True Range (ATR) 1.50 1.39
MACD 0.16 0.18
Stochastic Oscillator 97.14 82.93

Price Performance

Historical Comparison
TECX
ITG

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About ITG ITG Inc. Class A Common Stock

ITG Inc provides services to the digital and other utility infrastructure industries throughout the United States. Its services support the planning, design, construction, operation, maintenance, and expansion of broadband and other infrastructure networks. It operates through two complementary service lines: i) Engineering & Maintenance: It provides re-occurring, mission-critical services required by network owners to operate, maintain, optimize and expand their infrastructure. ii) Infrastructure Deployment. It provides large-scale network and fiber construction services for incumbent carriers, overbuilders, and data center operators and underground civil construction services for public and private utilities. The majority of revenue is derived from the Engineering & Maintenance services.

Share on Social Networks: